| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/09/2002 | CN1077568C Phenoxyphenyl cyclopentenyl hydroxyureas |
| 01/09/2002 | CN1077567C Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol |
| 01/09/2002 | CN1077566C 1-phenyl-3-dimethylaminopropane compounds with pharmacological effect |
| 01/09/2002 | CN1077435C Medicine for treating trachitis and preparation method thereof |
| 01/09/2002 | CN1077434C Chinese medicinal powder for treating toothache and preparation method thereof |
| 01/09/2002 | CN1077432C Medicine for treating haemorrhoids |
| 01/09/2002 | CN1077430C Combined hormonal contraception pharmacetuical preparation |
| 01/09/2002 | CN1077429C Preparation for epidermis and process for its preparation |
| 01/08/2002 | US6337423 Bind to voltage-gated sodium ion channels to modulate activity |
| 01/08/2002 | US6337411 Muscular disorders |
| 01/08/2002 | US6337408 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
| 01/08/2002 | US6337403 Triazole derivatives having antifungal activity |
| 01/08/2002 | US6337399 Condensation of isoindole with borate group with quinolone carboxylic acid |
| 01/08/2002 | US6337397 Pyrimidine derivatives and their salts, useful for making benzoxazepine derivatives |
| 01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 01/08/2002 | US6337349 Stable and nonhygroscopic salts to form tablets, capsules, powders, etc. suitable for dietary/nutritional humans supplements and a feed supplement for veterinary medicine; high-energy metabolism; cardiovascular systems |
| 01/08/2002 | US6337348 Inhibiting motility of sperm with oxovanadium compound with 1,10-phenanthroline, 2,2'bipyridine, 2'hydroxyacetophenone or 3-hydroxypropenal for complexes |
| 01/08/2002 | US6337346 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents |
| 01/08/2002 | US6337344 Anticoagulants and enzyme inhibitors for cardiovascular disorders |
| 01/08/2002 | US6337343 Amino acid derivatives |
| 01/08/2002 | US6337342 Bis-aryl or heteroaryl indoles |
| 01/08/2002 | US6337340 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 01/08/2002 | US6337339 Methods and compositions for treating infection using optically pure (S)-lomefloxacin |
| 01/08/2002 | US6337338 Heteroaryl-aryl ureas as IGF-1 receptor antagonists |
| 01/08/2002 | US6337335 Enzyme inhibitors for autoimmune diseases, transplant rejection, grant versus host disease, hyperproliferative disorders and diseases in which cells receive pro-inflammatory signals. |
| 01/08/2002 | US6337333 Method of treating autoimmune disease with fludarabine-5′-monophosphate |
| 01/08/2002 | US6337331 Triazolo-pyrimidine as ligands for GABA receptors |
| 01/08/2002 | US6337329 Vision defects and antiinflammatory agents |
| 01/08/2002 | US6337328 Bupropion metabolites and methods of use |
| 01/08/2002 | US6337327 Drugs for enzyme inhibiting such as angiotensin converting enzyme |
| 01/08/2002 | US6337325 Combined preparation for the therapy of immune diseases |
| 01/08/2002 | US6337324 Pharmaceutical combination |
| 01/08/2002 | US6337322 Administering an effective amount of ethanolamine, phospho ethanolamine, phosphoglycerolamine and salts |
| 01/08/2002 | US6337321 Treaatment of cardiovascular disorders in mammals |
| 01/08/2002 | US6337319 μ-Selective opioid peptides |
| 01/08/2002 | US6337209 Molecular constructs containing a carcinoembryonic antigen regulatory sequence |
| 01/08/2002 | US6337187 An isolated nucleic acid molecule; diagnosis and therapy for obesity, hypertriglyceridemia, and atherosclerosis |
| 01/08/2002 | US6337091 To maximally release its drug content in a controlled manner over a long time period while achieving complete dissolution |
| 01/08/2002 | US6337090 Orally administrable solid ribavirin dosage forms and process for making them |
| 01/08/2002 | US6337087 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/08/2002 | US6337083 Oral delivery method and composition for solid medications or dietary supplements |
| 01/08/2002 | US6337077 Composition with a continuous aqueous phase containing L-2-oxothiazolidine-4-carboxylic acid |
| 01/08/2002 | US6337076 Applying onto hypertrophic scar a liquid formulation comprising collodion film-forming carrier having dermatologically effective amount of active ingredient capable of reducing size of scar or improving appearance |
| 01/08/2002 | US6337065 For therapy of disorders such as sunburn and other skin deterioration that results from dna damage in skin cells |
| 01/08/2002 | CA2294614C Omeprazole sodium salt |
| 01/08/2002 | CA2251545C Spiro[cyclopent[b]indole-piperidines] and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors |
| 01/08/2002 | CA2205202C Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 01/08/2002 | CA2193087C Topical compositions comprising n-acetyl-l-cysteine |
| 01/08/2002 | CA2165821C Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 01/08/2002 | CA2161805C An exercise hydration regimen to enhance exercise endurance and performance |
| 01/08/2002 | CA2159450C 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors |
| 01/08/2002 | CA2155191C Method for manufacturing lactulose anhydride |
| 01/08/2002 | CA2150703C Substituted pyrazoles |
| 01/08/2002 | CA2143263C Orally administrable raloxifene formulations |
| 01/08/2002 | CA2135346C Natural mixture composed of higher primary aliphatic alcohols obtained from bee wax for the treatment of gastric and duodenal ulcers that also presents antiinflamatory activity |
| 01/08/2002 | CA2073981C 2-arylthiazole derivatives and pharmaceutical composition thereof |
| 01/08/2002 | CA2051356C Antineoplastic modified imidazoacridines |
| 01/08/2002 | CA2038744C Pharmaceutical composition containing slightly water-soluble drug |
| 01/08/2002 | CA2019622C Substituted arylamines and heteroarylamines, their preparation process and pharmaceutical composition containing them |
| 01/08/2002 | CA2019559C Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof |
| 01/03/2002 | WO2002102789A1 Antimicrobial and radioprotective compounds |
| 01/03/2002 | WO2002002088A2 Anthelmintic agents for preventing parasitic infections in humans and animals iii |
| 01/03/2002 | WO2002000844A2 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use |
| 01/03/2002 | WO2002000725A2 G-protein coupled receptor org10 |
| 01/03/2002 | WO2002000711A2 Ev-vegf nucleic acids and polypeptides and methods of use |
| 01/03/2002 | WO2002000682A1 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity |
| 01/03/2002 | WO2002000679A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/03/2002 | WO2002000676A1 Purine derivatives |
| 01/03/2002 | WO2002000665A1 Use of potassium channel openers for the treatment of insulitis |
| 01/03/2002 | WO2002000664A1 2-aminoalkyl-thieno[2,3-d]pyrimidines |
| 01/03/2002 | WO2002000663A2 Polycyclic xanthones as antibiotics |
| 01/03/2002 | WO2002000662A1 Improvements in and relating to chromophores |
| 01/03/2002 | WO2002000661A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS |
| 01/03/2002 | WO2002000660A1 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 01/03/2002 | WO2002000658A1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 01/03/2002 | WO2002000657A2 Condensed pyrazindione derivatives |
| 01/03/2002 | WO2002000656A2 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives |
| 01/03/2002 | WO2002000655A1 1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor xa inhibitors |
| 01/03/2002 | WO2002000654A1 Melanocortin receptor ligands |
| 01/03/2002 | WO2002000653A2 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/03/2002 | WO2002000652A1 Carbamates derived from arylalkylamines |
| 01/03/2002 | WO2002000650A2 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 01/03/2002 | WO2002000649A1 Substituted quinazoline derivatives and their use as inhibitors |
| 01/03/2002 | WO2002000647A1 Heteroaryl-phenyl substituted factor xa inhibitors |
| 01/03/2002 | WO2002000645A1 Indole derivatives useful for the treatment of cns disorders |
| 01/03/2002 | WO2002000641A2 Spla2 inhibitors |
| 01/03/2002 | WO2002000639A1 Synthesis of cyclic compounds |
| 01/03/2002 | WO2002000638A2 Substituted phthalides as anti-convulsive drugs |
| 01/03/2002 | WO2002000633A1 Quinolinyl and benzothiazolyl ppar-gamma modulators |
| 01/03/2002 | WO2002000632A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 01/03/2002 | WO2002000631A2 Benzhydryl derivatives |
| 01/03/2002 | WO2002000630A1 Polymorphic forms/hydrates of n-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride |
| 01/03/2002 | WO2002000629A1 Iminopyrimidine nmda nr2b receptor antagonists |
| 01/03/2002 | WO2002000626A1 Fused azepine derivatives and their use as antidiuretic agents |
| 01/03/2002 | WO2002000619A2 Alkyl ether modified polycyclic compounds having a terminal phenol as cell protecting agents |
| 01/03/2002 | WO2002000617A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | WO2002000616A2 Novel cephalosporin compounds and process for preparing the same |
| 01/03/2002 | WO2002000612A1 Glucagon antagonists/inverse agonists |
| 01/03/2002 | WO2002000611A2 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 01/03/2002 | WO2002000603A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |